| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |